About
David Leffell is the David Paige Smith Professor of Dermatology, Plastic Surgery, and Otolaryngology (emeritus) at the Yale School of Medicine, where he founded and led the section of Dermatologic Surgery and Cutaneous Oncology. He spent 15 years as CEO of the Yale Medical Group and served as deputy dean for clinical affairs, working on electronic medical records and clinical practice development. He earned his medical degree from McGill University and completed residencies in internal medicine, dermatology, and dermatologic surgery, and at Tullis he leads the scientific and clinical evaluation portions of the investment process.
Invests in
BiotechDigital HealthMedical Devices
Experience
- Yale School of MedicineDavid Paige Smith Professor of Dermatology & Surgery emerituscurrent1988 — presentNew Haven, CT
- Yale School of MedicineDeputy Dean for Clinical Affairs2005 — 2013
- Yale School of MedicineChief Executive Officer1997 — 2012New Haven, CT
- DocMatterBoard Observercurrent2021 — presentSan Francisco Bay Area
- SkinosiveBoard membercurrent2019 — present
- DERMASENSOR, INC.Scientific Advisory Boardcurrent2016 — presentWest Palm Beach, Florida, United States
- Tullis Health InvestorsVenture Partnercurrent2014 — presentGreenwich, Connecticut
- Leffell Global ConsultingPrincipalcurrent1995 — presentNew Haven, CT
- Xequel BioBoard member and Chief Medical Officer2019 — 2023Dallas, Texas, United States
- Hopkins SchoolTrustee2011 — 2021New Haven, CT
- Validus PharmaceuticalsMember Board of Directors2009 — 2021New Jersey
- Moerae Matrix, Inc.Scientific Advisor2012 — 2020
- Malin plcAdvisory Board2014 — 2017New Haven & Dublin
- CaresyncMember Board of Directors2014 — 2015Greater Tampa Bay Area
- Yale Medical GroupChief Executive Officer1996 — 2012
- Artspace New HavenPresident2008 — 2010New Haven CT
- Connecticut Public TelevisionBoard Member2000 — 2004Hartford, Connecticut, United States
Skills & more
Administration1Healthcare IT2Clinical Research78Medical Education48Healthcare72Management Consulting5Strategic Consulting5Healthcare Consulting14Healthcare Information Technology13Medical Devices28Medical Writing6Clinical Trials81
+12 more
BiotechnologySurgeryDermatologySystem AdministrationMedicineHealthcare ManagementInternal MedicineBoard CertifiedEMRPharmaceutical IndustryStrategic PlanningLeadershipLanguages French
From David's professional profile.
Deals · 1
FirstString ResearchBoard seat
via Tullis Health Investors · filed Jun 2021 · $30M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
BiologicsMDDermasensorDocMatter, Inc.SkinosiveTriSalus Life SciencesXequel Bio
Investor
NextEvo
Sources: the firm's website · SEC Form D filings.
Colleagues at Tullis Health Investors
Barbara Bierer
Venture Partner, MD at Tullis Health Investors
Darlene Franzé
Vice President, Administration at Tullis Health Investors
Jim Tullis
Founding Partner at Tullis Health Investors
John Tullis
Managing Partner at Tullis Health Investors
Julia Mende
Investment Associate at Tullis Health Investors
Melanie Oldeman
Vice President, Investor Communications at Tullis Health Investors
Naseer Robinson
Fund Controller at Tullis Health Investors
Pat Miles
Venture Partner at Tullis Health Investors
Frequently asked questions
- Who is David Leffell?
- David Leffell is the David Paige Smith Professor of Dermatology, Plastic Surgery, and Otolaryngology (emeritus) at the Yale School of Medicine, where he founded and led the section of Dermatologic Surgery and Cutaneous Oncology. He spent 15 years as CEO of the Yale Medical Group and served as deputy dean for clinical affairs, working on electronic medical records and clinical practice development. He earned his medical degree from McGill University and completed residencies in internal medicine, dermatology, and dermatologic surgery, and at Tullis he leads the scientific and clinical evaluation portions of the investment process.
- Where does David Leffell work?
- David Leffell is Chair of the THI Advisory Board at Tullis Health Investors.
- What does David Leffell invest in?
- David Leffell invests in Biotech, Digital Health, Medical Devices.
- What boards does David Leffell sit on?
- David Leffell holds tracked board seats at BiologicsMD, Dermasensor, DocMatter, Inc., FirstString Research, Skinosive, TriSalus Life Sciences, Xequel Bio.
- What companies has David Leffell invested in?
- Investments tracked here include NextEvo.
- Where did David Leffell go to school?
- David Leffell studied at Yale School of Medicine (Post-doctoral research, Dermatology); McGill University (M.D. CM, Medicine); University of Michigan Medical School (Fellowship, Advanced Dermatologic Surgery).
Same school
Also attended Yale School of Medicine33
Lars PedersenPartner, Chief Financial Officer at Redpoint VenturesAlexi Nazem, MDGeneral Partner at AlleyCorpJeffrey LowPartner at Averin CapitalBridget Martell MA, MDSenior Biopharmaceutical Advisor at Two Bear CapitalMax FarinaPrincipal at 5AM VenturesBrian YordyPrincipal at F-Prime Capital Partners
+ 27 more
Also attended McGill University425
Harley FinkelsteinInvestor at Felicis VenturesMattias LjungmanInvestor at Moonfire VenturesNoubar AfeyanInvestor at Flagship PioneeringDavid NaultGeneral Partner at Luge CapitalLaviva MazharPrincipal at Luge CapitalLisa PurcellInvestor at Third Rock Ventures
+ 419 more
Shared employers
Also worked at Yale School of Medicine38
Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Brittany de KouchkovskyDirector, University Relations at Osage University PartnersDavid Rosenthal, MDVenture Partner at AlleyCorpSophie RobinsonSenior Associate at Cure VenturesJonathan GertlerManaging Director at Bioventures InvestorsDouglas ReedGeneral Partner at Hatteras Venture Partners
+ 32 more
